Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. - Wikidata - wikimedia - TriplyDB

Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.

Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.

http://www.wikidata.org/entity/Q38442944

about

Notch Signaling in Neuroendocrine Tumors Targeting the Notch signaling pathway in cancer therapeutics Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors Medullary thyroid carcinoma: targeted therapies and future directions Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cells Valproic acid induces Notch1 signaling in small cell lung cancer cells Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells Identification of small molecule Hes1 modulators as potential anticancer chemotherapeutics.Signaling mechanisms in neuroendocrine tumors as targets for therapy.Novel approaches in anaplastic thyroid cancer therapy Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.Potential Therapeutic Role of Z-Isochaihulactone in Lung Cancer through Induction of Apoptosis via Notch Signaling.Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours.Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.Notch signaling in lung cancer.Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.Current understanding of the molecular biology of pancreatic neuroendocrine tumors.Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.Notch as a tumour suppressor.Raf-1 activation in gastrointestinal carcinoid cells decreases tumor cell adhesion.Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.

P2860

Q26752380-6C00FF36-7B2D-4DE5-8CC1-F3FC7B178E05 Q26863580-F8A60A40-6561-4461-8E09-4FA576FC9C2B Q28073184-0B88E746-9FDC-411C-BC76-B5EA90CDA0C5 Q33432714-3E8D9FFD-0B2D-4829-88B4-F97634F86589 Q33557376-F84EA495-AB4F-4834-BFDE-4E6B7D0F16B2 Q33804934-1FEC5D73-330B-40F0-BA67-066B889B2616 Q33861019-1F913B1B-A1AF-4F5F-A152-050B599456C7 Q33976203-DA3FE6D6-10EA-45A1-A232-0A94D72F3650 Q33998266-1C27F9AE-A3AD-42BF-9673-D8574B4DEFA1 Q34420344-86F8C342-1966-4C89-A8D9-06DE961C8515 Q34447484-8B1143C8-FB6D-47BB-8837-E0EAC181AA7B Q34458018-AB92ECF6-6595-4F14-B628-B30A094DC97D Q35050983-EF838549-64EF-43B8-8E07-7818147BFDFD Q35064499-E5589CCD-B3F7-423B-8F8C-AB2993F4EF15 Q35178600-E562069F-1978-48CF-B23B-D265DC3C2B6C Q35650633-C919D934-116E-4305-B315-8973FA4579A8 Q35776244-26271294-5276-4F5C-A06A-0D579EBFE35F Q36167254-6914C46E-8704-40E7-9D78-9B002DE342B8 Q36291949-A881F155-EAD4-43B8-BA87-24FBAF32508C Q36334183-687264AA-8CC8-4490-9E4B-D322278EF1FF Q36790872-DF9BCEC6-9AAB-4ABE-B7A7-8AD64C5D63E5 Q37089077-8DED5FDB-F684-4995-AC91-27BE383420A8 Q37179117-A9967DBD-98F3-4A66-9E2C-0C7F3835706B Q37332674-910D5F79-50E1-451D-9BB5-7170996F655F Q37339815-680062F0-029D-454B-9449-870709B3A70E Q37359642-C7A4E23D-92C4-4C8D-9229-FB45A48B914F Q37634917-8DFCE6AE-BF33-42AB-AAFE-C2FB5C720154 Q37866784-37FDD525-B9D0-446D-9623-215775CC857D Q37959323-E7981B17-AF22-4162-ABA0-A32FFE928B09 Q37985518-F7CBDFD6-034D-4596-9D98-569660771C16 Q37997894-A215D700-D79F-4239-8981-45A86875C5C2 Q38120515-760659FF-7295-4818-9AAD-9AA08F37C19C Q38730437-2C79BACC-FA89-4D8C-BB41-B46595286C71 Q39034721-28C5E58E-02EF-4216-B695-87A36CAA9CB7 Q39042894-20D191FC-E6BF-4AD1-B9CA-79003C053939 Q39116742-F9B7E176-F1EA-4375-B9D3-215B97B819CB Q40167201-3E9C35A2-08DF-44DC-8D88-82F13059F66A Q41712392-04C1229E-9896-47D4-9F3E-C275B7F99E5B Q44741799-EB585795-01FC-4F5D-91E3-1C86DD9EF0B4 Q47393972-6C445A41-884D-4748-8582-096AC622CDCC

P2860

Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.

http://www.wikidata.org/entity/Q38442944

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Regulation of neuroendocrine d ...... umor cells by notch signaling.

@en

type

label

Regulation of neuroendocrine d ...... umor cells by notch signaling.

@en

prefLabel

Regulation of neuroendocrine d ...... umor cells by notch signaling.

@en

P1433

Q38442944-7CDFB56B-6203-4AD0-AAE6-E01DFD0BA27F

P1476

Q38442944-65F7AFE6-7188-43B4-9F75-68D0A9DA8FEB

P2093

Q38442944-02678B91-1D62-4618-B2B5-F77DE5A1FF47

Q38442944-25C389B5-F5DB-44EA-9587-F72445A4D8A1

Q38442944-9E1449D9-D4C4-4CDE-9FB0-DE9A2D596258

Q38442944-9E4D16C7-765D-4870-9814-947977200F81

Q38442944-AFCCBE00-5C61-4410-BA4E-97F77D7BF99C

Q38442944-BFF5FDE2-426B-4A14-9ECA-D6F57F51DEFF

Q38442944-C3271134-12AE-465F-91AD-1F0798C7F049

Q38442944-DDE541E6-D5BB-44F6-A62E-3B46BD18E63A

Q38442944-E9863D2A-86C9-475D-8F9E-09ACDC66FDC5

Q38442944-F1E006AD-D7C4-4494-BBC4-478A975D9D66

P304

Q38442944-71F2AADB-BE3D-4E8C-835D-EF86A14C8465

P31

Q38442944-C7E55AB2-1504-41F7-9163-61B0ED992785

P356

Q38442944-7B106783-822F-42A2-8C69-24C4C0D5C81E

P407

Q38442944-10AE7D51-EB00-4A27-8537-EB7852077222

P433

Q38442944-622E87A3-F3B2-487A-B060-E8B5C8C256AE

P478

Q38442944-3F588E82-2397-451A-B3AA-750E254AB16D

P577

Q38442944-9669D935-598F-43C0-84E2-DF0622099A8D

P5875

Q38442944-029C4ED2-4925-450D-9585-DB10A555AABD

P698

Q38442944-81D7D7F6-6A92-431A-A0D0-E27CC86C8921

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Regulation of neuroendocrine d ...... umor cells by notch signaling.

@en

P2093

Barry D Nelkin

http://www.w3.org/2001/XMLSchema#string

Brendan J Collins

http://www.w3.org/2001/XMLSchema#string

Douglas W Ball

http://www.w3.org/2001/XMLSchema#string

Edward C Hsiao

http://www.w3.org/2001/XMLSchema#string

Eric K Nakakura

http://www.w3.org/2001/XMLSchema#string

Herbert Chen

http://www.w3.org/2001/XMLSchema#string

Kornel E Schuebel

http://www.w3.org/2001/XMLSchema#string

Michael W Borges

http://www.w3.org/2001/XMLSchema#string

Muthusamy Kunnimalaiyaan

http://www.w3.org/2001/XMLSchema#string

Ning Jin

http://www.w3.org/2001/XMLSchema#string

P304

4350-4356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2005-0540

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7868520

http://www.w3.org/2001/XMLSchema#string

P698

15870121

http://www.w3.org/2001/XMLSchema#string